Therapeutic efficacy of platelet components treated with amotosalen and ultraviolet A pathogen inactivation method: results of a meta-analysis of randomized controlled trials

A multi-centre study of therapeutic efficacy and safety of platelet components treated with amotosalen and ultraviolet A pathogen inactivation stored for 6 or 7 d prior to transfusion

(2011) Miguel Lozano et al.   BRITISH JOURNAL OF HAEMATOLOGY

Fever with Thrombocytopenia Associated with a Novel Bunyavirus in China

(2011) Xue-Jie Yu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Adjudicating bleeding events in a platelet dose study: impact on outcome results and challenges

(2011) Nancy M. Heddle et al.   TRANSFUSION

Meta-analysis of the studies of bleeding complications of platelets pathogen-reduced with the Intercept system

(2011) E. C. Vamvakas   VOX SANGUINIS

Meta-analysis of the randomized controlled trials of the hemostatic efficacy and capacity of pathogen-reduced platelets

(2010) Eleftherios C. Vamvakas   TRANSFUSION

Time to rethink clinically important outcomes in platelet transfusion trials

(2010) Nancy M. Heddle et al.   TRANSFUSION

A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology

(2010) J-P. Cazenave et al.   TRANSFUSION

Transfusion-associated infections: 50 years of relentless challenges and remarkable progress

(2010) Herbert A. Perkins et al.   TRANSFUSION

BLOOD COMPONENTS: Screening of single-donor apheresis platelets for bacterial contamination: the PASSPORT study results

(2009) Larry J. Dumont et al.   TRANSFUSION

Limiting and detecting bacterial contamination of apheresis platelets: inlet-line diversion and increased culture volume improve component safety

(2009) Anne F. Eder et al.   TRANSFUSION

Dengue and Chikungunya viruses in blood donations: risks to the blood supply?

(2008)   TRANSFUSION